NEOLA — Neola Medical AB Share Price
0.000.00%
Last trade - 00:00- SEK175.38m
- SEK155.82m
- 10
- 14
- 50
- 12
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.54 | ||
| Price to Tang. Book | 10.57 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -15.66% | ||
| Return on Equity | -13.6% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 0.03 | 0.63 | n/a | n/a | n/a | 11 | 20 | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on the patented GASMAS (Gas in Scattering Media Absorption Spectroscopy) technology. Neola Medical's technology equipment aims for continuous monitoring of the lungs of premature babies. The primary purpose of Neola Medical is to support neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts about life-threatening complications using new technology that measures lung volume changes and oxygen concentration.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 11th, 2016
- Public Since
- October 2nd, 2020
- No. of Employees
- 8
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 70,150,234
- Address
- Ideon Science Park, Scheelevagen 27, LUND, 223 63
- Web
- https://www.neolamedical.se/
- Phone
- +46 46540540
- Auditors
- KPMG AB
Upcoming Events for NEOLA
Neola Medical AB Annual Shareholders Meeting
Similar to NEOLA
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Neola Medical AB share price?
As of Today at 22:14 UTC, shares in Neola Medical AB are trading at SEK2.50. This share price information is delayed by 15 minutes.
How has the Neola Medical AB share price performed this year?
Shares in Neola Medical AB last closed at SEK2.50 and the price had moved by +32.28% over the past 365 days. In terms of relative price strength the Neola Medical AB share price has outperformed the FTSE Global All Cap Index by +28.96% over the past year.
What are the analyst and broker recommendations for Neola Medical AB?
There is no consensus recommendation for this security.
Find out moreWhat is the Neola Medical AB dividend yield?
Neola Medical AB does not currently pay a dividend.
Does Neola Medical AB pay a dividend?
Neola Medical AB does not currently pay a dividend.
When does Neola Medical AB next pay dividends?
Neola Medical AB does not currently pay a dividend.
How do I buy Neola Medical AB shares?
To buy shares in Neola Medical AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Neola Medical AB?
As of the previous close price of SEK2.50, shares in Neola Medical AB had a market capitalisation of SEK175.38m.
Where are Neola Medical AB shares listed?
Here are the trading details for Neola Medical AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: NEOLA
What kind of share is Neola Medical AB?
Based on an overall assessment of its quality, value and momentum Neola Medical AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Neola Medical AB share price forecast for 2025?
The analyst consensus target price for shares in Neola Medical AB is SEK3.20. That is 28% above the last closing price of SEK2.50.
Analysts covering Neola Medical AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.20 for the next financial year.
Find out moreWhat is the trend in the Neola Medical AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Neola Medical AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +2.33%.
As of the last closing price of SEK2.50, shares in Neola Medical AB were trading -3.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Neola Medical AB PE Ratio?
The Neola Medical AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK2.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Neola Medical AB?
We do not have data on Neola Medical AB's directors